Evolus, Inc.
EOLS · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.57 | 0.87 | -0.06 | 0.40 |
| FCF Yield | -4.23% | -4.29% | -2.28% | 0.51% |
| EV / EBITDA | -53.42 | -87.76 | -65.87 | 1,159.35 |
| Quality | ||||
| ROIC | -7.51% | -6.12% | -9.57% | -1.44% |
| Gross Margin | 66.47% | 65.31% | 68.09% | 63.77% |
| Cash Conversion Ratio | 0.93 | 1.45 | 0.83 | -0.71 |
| Growth | ||||
| Revenue 3-Year CAGR | 15.66% | 18.13% | 20.76% | 21.46% |
| Free Cash Flow Growth | 33.96% | -45.65% | -607.63% | 148.32% |
| Safety | ||||
| Net Debt / EBITDA | -11.69 | -11.89 | -4.95 | 68.84 |
| Interest Coverage | -2.81 | -1.42 | -3.44 | -0.51 |
| Efficiency | ||||
| Inventory Turnover | 0.70 | 0.91 | 2.18 | 2.35 |
| Cash Conversion Cycle | 104.39 | 73.64 | 37.02 | 63.55 |